Genpact Limited (NYSE:G - Get Free Report) has earned an average recommendation of "Hold" from the nine research firms that are covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $48.44.
G has been the subject of several research reports. Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Needham & Company LLC lifted their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Robert W. Baird lifted their price target on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th.
Get Our Latest Stock Report on Genpact
Genpact Price Performance
Genpact stock traded up $0.52 during midday trading on Wednesday, reaching $53.22. The company's stock had a trading volume of 2,318,410 shares, compared to its average volume of 1,559,439. Genpact has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The stock's 50 day simple moving average is $48.00 and its 200 day simple moving average is $43.38. The firm has a market capitalization of $9.39 billion, a PE ratio of 18.74, a P/E/G ratio of 1.84 and a beta of 1.20.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts forecast that Genpact will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.28%. Genpact's payout ratio is presently 23.94%.
Insider Activity at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares of the company's stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by corporate insiders.
Institutional Trading of Genpact
Institutional investors have recently modified their holdings of the company. Coppell Advisory Solutions LLC grew its holdings in shares of Genpact by 529.5% during the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the period. SRH Advisors LLC purchased a new position in Genpact in the 4th quarter worth approximately $26,000. Atlas Capital Advisors Inc. boosted its holdings in Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares during the period. GeoWealth Management LLC boosted its holdings in Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after acquiring an additional 583 shares during the period. Finally, Manchester Capital Management LLC purchased a new position in Genpact in the 4th quarter worth approximately $38,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Genpact Company Profile
(
Get Free ReportGenpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.